Pauline Cafferkey is a Scottish nurse and aid worker who contracted Ebola virus disease in 2014 while working in Sierra Leone as part of the medical aid effort during the West African Ebola virus epidemic. She survived the illness.
On 29 December 2014, Cafferkey, who had just returned to Glasgow from Sierra Leone via Casablanca Airport and London Heathrow Airport, was diagnosed with Ebola virus disease at Glasgow's Gartnavel General Hospital. [1] [2] [3] She had been working at an Ebola treatment centre in Kerry Town in Sierra Leone, [2] and it is thought she contracted the virus as a result of wearing a visor, as recommended by the World Health Organization and the UK Ministry of Defence, instead of goggles. [4]
After initial treatment in Glasgow, she was transferred by air to RAF Northolt, then to the specialist high-level isolation unit at the Royal Free Hospital in London for longer-term treatment. [2] [5] A Scottish government spokesman described the risk to the general public as "extremely low to the point of negligible" due to the very early stage of the infection at the time of detection. [2] Contact tracing was carried out on the other passengers who traveled on the flight from London to Glasgow with her. [5] Medical staff described her condition at the time as "as well as we can hope for at this stage." [6]
On 4 January 2015, the Royal Free Hospital announced that her condition had deteriorated to critical, [7] with her health later stabilising before she was declared no longer critically ill on 12 January. [8] [9] Cafferkey received blood plasma from William Pooley and has been treated with experimental drugs as part of her treatment. [9] On 24 January, she was declared to be free of infection, and released from hospital. [10]
The prognosis after recovery from Ebola virus disease can include joint pains, muscular pain, skin peeling, or hair loss. [11] [12] [13] In a media interview in September 2015, Cafferkey said "I’ve had trouble with my thyroid, lost some of my hair and get really sore joints but I guess side effects are to be expected." [14]
It was found in 2015 that, after an apparent complete cure, with the bloodstream, saliva and organs such as the liver free of the Ebola virus, it can linger on in parts of the body not protected by the immune system, including fluid in the eye, the central nervous system and, in men, the testes and semen. [15]
Cafferkey went to a 24-hour GP clinic in New Victoria Hospital in Glasgow on the night of 5 October 2015 and was diagnosed with "a virus" (unspecified) and sent home. [16] 24 hours later she was admitted to Queen Elizabeth University Hospital where she was diagnosed with late complications caused by the Ebola virus hitherto considered unusual, and was flown by military jet to London, to the Royal Free Hospital. Her condition was initially described as serious and she was being treated in the high-level isolation unit. Doctors discovered that, after she had been deemed cured, the virus had remained in her cerebrospinal fluid and feared that it might be in her central nervous system. [15] Personnel in Scotland monitored those whom she had come into contact with, since the virus can be spread through exposure to the infected person's body fluids, though they said the risk was likely to be small. [17]
Cafferkey's condition declined rapidly, and on 14 October 2015 she was reported to be critically ill. [18] Five days later, on 19 October 2015, the Royal Free Hospital announced that: "Pauline Cafferkey's condition has improved to serious but stable". [19] On 21 October 2015 Dr Michael Jacobs, Cafferkey's doctor at the Royal Free Hospital, said at a televised press conference that Cafferkey was suffering from neurological complications from meningitis caused by Ebola virus, and had not been re-infected with Ebola, was being treated using a highly experimental anti-viral agent called GS5734, and had significantly improved, although she remained in an isolation tent and was not well enough to get out of bed. [20] [21] [22] On 12 November the Royal Free Hospital said that Cafferkey had made a full recovery and was no longer infectious. [23] She was transferred to Glasgow's Queen Elizabeth University Hospital. [24]
In February 2016, Cafferkey was admitted to Glasgow's Queen Elizabeth University Hospital after "routine monitoring by the Infectious Diseases Unit". On the same day she was transferred by a RAF plane to London where she was readmitted to the Royal Free Hospital. In a statement the Royal Free said she had been transferred to the hospital "due to a late complication from her previous infection by the Ebola virus" and that she was being treated by the hospital's infectious diseases team. On 24 February the hospital described her condition as "stable". [25] On 28 February Cafferkey was discharged by the Royal Free Hospital. A spokesman said, "We can confirm that Pauline is not infectious. The Ebola virus can only be transmitted by direct contact with the blood or bodily fluids of an infected person while they are symptomatic." [26]
On 6 October 2016 she was readmitted to the Queen Elizabeth University Hospital to be monitored by the infectious diseases team. A NHS Greater Glasgow and Clyde spokeswoman said that she was in a stable condition and undergoing investigations. [27] [28] In the evening of the same day a statement was issued stating that tests for the Ebola virus were negative. [29]
In 2014, due to the fact that Cafferkey had passed through border controls and travelled on a domestic flight from Heathrow to Glasgow, criticism was levelled at current screening protocols at UK points of entry, which mainly consisted of taking a person's temperature and asking a series of questions. [30] Public Health England stated that they were planning a review of the screening procedures. [31]
In 2016, the Nursing and Midwifery Council initiated proceedings against Cafferkey, alleging that she had allowed an incorrect temperature to be recorded during the screening process upon returning to the UK from Sierra Leone in 2014. Following a two-day hearing in Edinburgh during September 2016, the charges against Cafferkey were dismissed and she was cleared of any wrongdoing. The disciplinary panel was told that she had been impaired by illness at the time and heard evidence about how the Public Health England screening centre at Heathrow Airport had been unprepared for a large influx of passengers and that it was "busy, disorganised and even chaotic". BBC Scotland reporter Philip Sim wrote: "It now seems as if the case against Pauline Cafferkey had fallen apart before the hearing even began - raising questions as to why she had to go through it in the first place". [32] [33] In November 2016, a second panel criticised fellow volunteer senior nurse Donna Wood for suggesting "let's put it down as 37.2 and get out of here and sort it out later". [34] Wood was suspended for two months for failing to alert the authorities about Cafferkey's condition. [34] Hannah Ryan, the doctor that agreed to record the incorrect temperature, was suspended for one month by the Medical Practitioners Tribunal in March 2017. [35]
In April 2017, Cafferkey announced she would return to Sierra Leone in May to raise funds for Ebola survivors and children orphaned by the disease. [36]
In June 2019, Cafferkey gave birth to twin sons in a hospital in Glasgow, at the age of 43. [37] [38] In a statement, she said "this shows that there is life after Ebola and there is a future for those who have encountered this disease". [39]
The Royal Free Hospital is a major teaching hospital in the Hampstead area of the London Borough of Camden. The hospital is part of the Royal Free London NHS Foundation Trust, which also runs services at Barnet Hospital, Chase Farm Hospital and a number of other sites. The trust is a founder member of the UCLPartners academic health science centre.
Gartnavel General Hospital is a teaching hospital in the West End of Glasgow, Scotland. The hospital is located next to the Great Western Road, between Hyndland, Anniesland and Kelvindale. Hyndland railway station is adjacent to the hospital. The name Gartnavel is derived from the Gaelic GartUbhal (apple) – i.e. "a field of apple trees". It is managed by NHS Greater Glasgow and Clyde.
Ebola, also known as Ebola virus disease (EVD) and Ebola hemorrhagic fever (EHF), is a viral hemorrhagic fever in humans and other primates, caused by ebolaviruses. Symptoms typically start anywhere between two days and three weeks after infection. The first symptoms are usually fever, sore throat, muscle pain, and headaches. These are usually followed by vomiting, diarrhoea, rash and decreased liver and kidney function, at which point some people begin to bleed both internally and externally. It kills between 25% and 90% of those infected – about 50% on average. Death is often due to shock from fluid loss, and typically occurs between six and 16 days after the first symptoms appear. Early treatment of symptoms increases the survival rate considerably compared to late start. An Ebola vaccine was approved by the US FDA in December 2019.
The 2013–2016 epidemic of Ebola virus disease, centered in Western Africa, was the most widespread outbreak of the disease in history. It caused major loss of life and socioeconomic disruption in the region, mainly in Guinea, Liberia and Sierra Leone. The first cases were recorded in Guinea in December 2013; later, the disease spread to neighbouring Liberia and Sierra Leone, with minor outbreaks occurring in Nigeria and Mali. Secondary infections of medical workers occurred in the United States and Spain. In addition, isolated cases were recorded in Senegal, the United Kingdom and Italy. The number of cases peaked in October 2014 and then began to decline gradually, following the commitment of substantial international resources.
Sheik Umar Khan was the chief Sierra Leonean doctor attempting to curb the country's Ebola outbreak in 2014.
An Ebola virus epidemic in Sierra Leone occurred in 2014, along with the neighbouring countries of Guinea and Liberia. At the time it was discovered, it was thought that Ebola virus was not endemic to Sierra Leone or to the West African region and that the epidemic represented the first time the virus was discovered there. However, US researchers pointed to lab samples used for Lassa fever testing to suggest that Ebola had been in Sierra Leone as early as 2006.
An epidemic of Ebola virus disease in Guinea from 2013 to 2016 represents the first ever outbreak of Ebola in a West African country. Previous outbreaks have been confined to several countries in Sub-Saharan Africa.
An epidemic of Ebola virus disease occurred in Liberia from 2014 to 2015, along with the neighbouring countries of Guinea and Sierra Leone. The first cases of virus were reported by late March 2014. The Ebola virus, a biosafety level four pathogen, is an RNA virus discovered in 1976.
Four laboratory-confirmed cases of Ebola virus disease occurred in the United States in 2014. Eleven cases were reported, including these four cases and seven cases medically evacuated from other countries. The first was reported in September 2014. Nine of the people contracted the disease outside the US and traveled into the country, either as regular airline passengers or as medical evacuees; of those nine, two died. Two people contracted Ebola in the United States. Both were nurses who treated an Ebola patient; both recovered.
Organizations from around the world responded to the West African Ebola virus epidemic. In July 2014, the World Health Organization (WHO) convened an emergency meeting with health ministers from eleven countries and announced collaboration on a strategy to co-ordinate technical support to combat the epidemic. In August, they declared the outbreak an international public health emergency and published a roadmap to guide and coordinate the international response to the outbreak, aiming to stop ongoing Ebola transmission worldwide within 6–9 months. In September, the United Nations Security Council declared the Ebola virus outbreak in the West Africa subregion a "threat to international peace and security" and unanimously adopted a resolution urging UN member states to provide more resources to fight the outbreak; the WHO stated that the cost for combating the epidemic will be a minimum of $1 billion.
The Hospital Carlos III is a public hospital in the city of Madrid. It belongs to the Servicio Madrileño de Salud, the health service of the Community of Madrid. It was crested in 1990 from the merger of three previous hospitals, and was established as a center of excellence in research and treatment of infectious diseases.
In 2014, Ebola virus disease in Spain occurred due to two patients with cases of the disease contracted during the Ebola virus epidemic in West Africa; they were medically evacuated. A failure in infection control in the treatment of the second patient led to an isolated infection of Ebola virus disease in a health worker in Spain itself. The health worker survived her Ebola infection, and has since been declared infection-free.
This article covers the timeline of the 2014 Ebola virus epidemic in West Africa and its outbreaks elsewhere. Flag icons denote the first announcements of confirmed cases by the respective nation-states, their first deaths, and their first secondary transmissions, as well as relevant sessions and announcements of agencies such as the World Health Organization (WHO), the U.S. Centers for Disease Control (CDC), and NGOs such as Doctors Without Borders; medical evacuations, visa restrictions, border closures, quarantines, court rulings, and possible cases of zoonosis are also included.
Ebola virus disease in Mali occurred in October 2014, leading to concern about the possibility of an outbreak of Ebola in Mali. A child was brought from Guinea and died in the northwestern city of Kayes. Mali contact traced over 100 people who had contact with the child; tracing was completed in mid-November with no further cases discovered. In November, a second unrelated outbreak occurred in Mali's capital city, Bamako. Several people at a clinic are thought to have been infected by a man traveling from Guinea. On January 18, Mali was declared Ebola-free after 42 days with no new cases. There had been a cumulative total of eight cases with six deaths.
The Ebola virus epidemic in West Africa has had a large effect on the culture of most of the West African countries. In most instances, the effect is a rather negative one as it has disrupted many Africans’ traditional norms and practices. For instance, many West African communities rely on traditional healers and witch doctors, who use herbal remedies, massage, chant and witchcraft to cure just about any ailment. Therefore, it is difficult for West Africans to adapt to foreign medical practices. Specifically, West African resistance to Western medicine is prominent in the region, which calls for severe distrust of Western and modern medical personnel and practices.(see Ebola conspiracies below.)
Ebola virus disease in the United Kingdom and Ireland has occurred rarely in four cases to date, namely three health workers returning from treating victims of the Ebola virus epidemic in West Africa in 2014 and 2015, and a single case in 1976, when a laboratory technician contracted the disease in a needlestick injury while handling samples from Africa. All cases recovered. As of 2023, no domestic transmission of Ebola has occurred in the United Kingdom or Ireland.
Kerry Town is a village in the Rural District in the Western Area of Sierra Leone. the town is located about 31 kilometres (19 mi) from the national capital, Freetown, which lies to the west-north-west. The population of Kerry Town is largely from the Krio ethnic group. The Treatment of the Ebola Virus clinic is located in Kerry Town.
Cases of the Ebola virus disease in Nigeria were reported in 2014 as a small part of the epidemic of Ebola virus disease which originated in Guinea that represented the first outbreak of the disease in a West African country. Previous outbreaks had been confined to countries in Central Africa.
Ian Crozier is an American physician who contracted Ebola virus disease in September 2014, while working in West Africa.
Nahid Bhadelia is an American infectious-diseases physician, founding director of Center for Emerging Infectious Diseases Policy and Research (CEID) at Boston University and an associate professor at the Boston University School of Medicine. She served as the Senior Policy Advisor for Global COVID-19 Response on the White House COVID-19 Response Team.